fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

CARMAT launches a capital increase for an initial amount of €46 million

Download

First implantation in the Czech Republic within the framework of the PIVOTAL study international expansion

Download

CARMAT signs a partnership agreement with AddUp

Download

CARMAT accelerates the internationalization of the PIVOTAL study and obtains the approval to perform implants in the Czech Republic

Download

International implant of the CARMAT heart

Download

CARMAT expands its PIVOTAL study internationally, in line with its clinical strategy and CE marking process

Download

2017 half-year results

Download

CARMAT appoints Francesco Arecchi, previously Product Manager EMEA Structural Heart at Abbott, as Marketing Manager

Download
Top of page